Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (585) clinical trials

Research study of an investigational Alzheimer’s medication taken twice daily for people with early-stage Alzheimer’s Disease. In this research study, doctors want to test the safety and effectiveness of 4 different doses of the study drug and compare it to placebo in participants with early-stage Alzheimer’s Disease

Phase N/A

Research study of an investigational Alzheimer’s medication taken twice daily for people with mild Alzheimer's Disease. In this research study, doctors want to test the safety and effectiveness of 4 different doses of the study drug and compare it to donepezil and placebo in participants with Alzheimer’s Disease.

Phase N/A

The purpose of this trial is to assess the efficacy and safety of MK-8931 compared with placebo in the treatment of amnestic mild cognitive impairment (aMCI) due to Alzheimer's Disease (AD), also known as prodromal AD. Participants will be randomized to receive placebo, or 12 mg or 40 mg MK-8931, ...

Phase

This is an 18 month study in which subjects that screen and qualify will go onto the program taking the investigational medication by mouth once daily.

Phase N/A

California Neuroscience Research is conducting a research study on the effectiveness and safety of an investigational medication or placebo in patients with mild Alzheimer’s disease. The study has up to 31 office visits over up to 40 months. Participants will receive an investigational medication or placebo monthly by subcutaneous injection. ...

Phase N/A

A Phase III, Randomized, Placebo-Controlled, Double Blind Clinical Trial to study the Efficacy and Safety of MK-8931 in Subjects with Amnestic Mild Cognitive Impairment (aMCI) due to Alzheimer’s Disease (prodromal AD).M

Phase N/A

52 week duration Lab testing physical exams mental scales PET and MRI scans

Phase

Researchers are conducting a local research study for an investigational drug in people with mild Alzheimer's disease.

Phase

Are you or someone you care for experiencing memory loss possibly due to Alzheimer's disease?

Phase

EXPEDITION 3 will look at whether the investigational drug solanezumab can help slow the worsening of AD in patients with mild disease. Study duration will be approximately 18 months, followed by an optional open-label extension study. Participants will be randomized in a 1:1 ratio to receive solanezumab or placebo by ...

Phase